Login / Signup

The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers.

Deirdre WeymannJanessa LaskinRobyn RoscoeKasmintan A SchraderStephen ChiaStephen YipWinson Y CheungKaren A GelmonAly KarsanDaniel J RenoufMarco MarraDean A Regier
Published in: Molecular genetics & genomic medicine (2017)
WGA costs decreased over the studied time horizon, but expenditures needed to realize WGA remain significant. Future research exploring costs and benefits of WGA-guided cancer care are crucial to guide health policy.
Keyphrases
  • public health
  • healthcare
  • mental health
  • current status
  • health information
  • risk assessment
  • young adults
  • replacement therapy